NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Collins Helen Louise

Filed: 2026-04-21 AccNo: 0001701247-26-000006 Size: 13 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/22 00:40 UTC
首次发现04/22 00:46 UTC
热度106.2
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 465 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001701247-26-000006

Filing Date: 2026-04-21

Accepted: 2026-04-21 20:40:17

Documents: 1

Period of Report: 2026-04-17

Enliven Therapeutics, Inc. ( Issuer ) CIK : 0001672619 (see all company filings) EIN. : 811523849 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | form4-04222026_120411.xml | 4 | 12313